Skip to main content

Mobile Main Navigation

  • About
    • Background
    • Leadership
    • Scientific and Programmatic Support
    • Grantees
  • Grants & Resources
    • Grants & Resources
    • Types of Grants
    • How to Apply
  • Harvard Resources
  • Projects

Mobile Utility Navigation

  • Harvard Medical School
  • MyHMS
Menu

Utility Navigation

  • Harvard Medical School
  • MyHMS
Search

Main navigation

  • About
    • Background
    • Leadership
    • Scientific and Programmatic Support
    • Grantees
  • Grants & Resources
    • Grants & Resources
    • Types of Grants
    • How to Apply
  • Harvard Resources
  • Projects

Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects

Snehal N. Chaudhari, David A. Harris, Hassan Aliakbarian, James N. Luo, Matthew T. Henke, Renuka Subramaniam, Ashley H. Vernon, Ali Tavakkoli, Eric G. Sheu & A. Sloan Devlin
Download PDF
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects_0.pdf (2.48 MB)
Sloan Devlin
2020-08
2020
Nature
Harvard Medical School
Facebook linkedin instagram youtube

401 Park Drive
Suite 505
Boston, MA 02215
(617) 384-8500

Footer

  • Accessibility
  • Digital Accessibility​

User account menu

  • Log in

© 2025 by the President and Fellows of Harvard College